84 related articles for article (PubMed ID: 8882022)
1. Treatment of rheumatoid arthritis by immunization with mononuclear white blood cells: results of a preliminary trial.
Smith JB; Fort JG
J Rheumatol; 1996 Feb; 23(2):220-5. PubMed ID: 8882022
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
Wendling D; Racadot E; Wijdenes J; Sibilia J; Flipo RM; Cantagrel A; Miossec P; Eschard JP; Macro M; Bertin P; Lioté F; Debiais F; Juvin R; Le Goff P; Masson C
J Rheumatol; 1998 Aug; 25(8):1457-61. PubMed ID: 9712083
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.
Furuzawa-Carballeda J; Cabral AR; Zapata-Zuñiga M; Alcocer-Varela J
J Rheumatol; 2003 Feb; 30(2):256-9. PubMed ID: 12563677
[TBL] [Abstract][Full Text] [Related]
4. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
[TBL] [Abstract][Full Text] [Related]
5. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
6. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
7. Effects of Prosorba column apheresis in patients with chronic refractory rheumatoid arthritis.
Roth S
J Rheumatol; 2004 Nov; 31(11):2131-5. PubMed ID: 15517623
[TBL] [Abstract][Full Text] [Related]
8. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
[TBL] [Abstract][Full Text] [Related]
9. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.
Stone M; Fortin PR; Pacheco-Tena C; Inman RD
J Rheumatol; 2003 Oct; 30(10):2112-22. PubMed ID: 14528503
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Choy EH; Isenberg DA; Garrood T; Farrow S; Ioannou Y; Bird H; Cheung N; Williams B; Hazleman B; Price R; Yoshizaki K; Nishimoto N; Kishimoto T; Panayi GS
Arthritis Rheum; 2002 Dec; 46(12):3143-50. PubMed ID: 12483717
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
Paulus HE; Bulpitt KJ; Ramos B; Park G; Wong WK;
Arthritis Rheum; 2000 Dec; 43(12):2743-50. PubMed ID: 11145032
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis.
Paran D; Elkayam O; Mayo A; Paran H; Amit M; Yaron M; Caspi D
Ann Rheum Dis; 2001 Sep; 60(9):888-91. PubMed ID: 11502617
[TBL] [Abstract][Full Text] [Related]
13. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
[TBL] [Abstract][Full Text] [Related]
14. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
15. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
16. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
[TBL] [Abstract][Full Text] [Related]
17. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT
J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
Barnett ML; Kremer JM; St Clair EW; Clegg DO; Furst D; Weisman M; Fletcher MJ; Chasan-Taber S; Finger E; Morales A; Le CH; Trentham DE
Arthritis Rheum; 1998 Feb; 41(2):290-7. PubMed ID: 9485087
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
